Myr5A peptide is an acylated peptide composed of an apolipoprotein A1 (ApoA1)-mimicking peptide, known as the 5A peptide, conjugated with the saturated fatty acid myristic acid. This peptide self-assembles into lipid nanostructures and has been utilized for encapsulating the anthracyclines doxorubicin and valrubicin in studies of in vitro compound release.